Immunopathology of RSV: An Updated Review
Keyword(s):
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.
1995 ◽
Vol 32
(4)
◽
pp. 266-269
Keyword(s):
2010 ◽
Vol 35
(1)
◽
pp. 72-77
◽
1988 ◽
Vol 2
(4)
◽
pp. 269-278
◽
Keyword(s):
Keyword(s):